NYSE$HUM
Humana Inc · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Reported a GAAP loss per share of $4.42 and an adjusted loss per share of $0.11 for Q4 2023, reflecting increased Medicare Advantage medical cost trends.
Humana reported a net loss per share of $4.42 on a GAAP basis and an adjusted loss per share of $0.11 for the fourth quarter of 2023. The results were impacted by rising Medicare Advantage medical costs. The company provided initial full-year 2024 EPS guidance of approximately $14.87 on a GAAP basis and approximately $16.00 on an adjusted basis.
- Reports 4Q23 loss per share of $4.42 on a GAAP basis, Adjusted loss per share of $0.11; reports FY 2023 earnings per share (EPS) of $20.00 on a GAAP basis, $26.09 on an Adjusted basis
- 4Q23 results reflect additional increase in Medicare Advantage medical cost trends, driven by higher than anticipated inpatient utilization, primarily for the months of November and December, and a further increase in non-inpatient trends
- Announces initial FY 2024 EPS guidance of 'approximately $14.87' on a GAAP basis, 'approximately $16.00' on an Adjusted basis; assumes the higher Medicare Advantage medical costs experienced in 4Q23 persist throughout 2024
- Affirms 2024 individual Medicare Advantage annual membership growth of approximately 100,000 or 1.8 percent
Headline financials
Revenue & EPS history
Humana · Revenue · Quarterly
$26.5B
Revenue by segment
Humana · $25.5B total across 1 segment · Q3 2023
- Insurance$25.5B—100.0%
Forward guidance
Humana provided its initial GAAP and Adjusted EPS guidance for the year ending December 31, 2024 (FY 2024).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
+0.9%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+2.8%
Avg return
30 days after
62%
45 / 73 earnings
Positive
+12.4%
Q2 2025
Best reaction
-12.6%
Q2 2012
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +5.5% | +3.6% | +33.3% | |
| Q4 2025 | -3.3% | +1.5% | -8.8% | |
| Q3 2025 | -6.0% | -15.4% | -8.5% | |
| Q2 2025 | +12.4% | +6.3% | +30.5% | |
| Q1 2025 | +1.1% | -1.0% | -10.1% | |
| Q4 2024 | -3.5% | -4.9% | -5.6% | |
| Q3 2024 | +0.0% | -0.9% | +15.0% | |
| Q2 2024 | -11.3% | -11.9% | -12.4% | |
| Q1 2024 | -5.1% | -7.6% | +6.5% | |
| Q4 2023 | -10.2% | -6.4% | -9.8% | |
| Q3 2023 | -8.1% | -6.9% | -5.4% | |
| Q2 2023 | +6.3% | +8.0% | +0.5% | |
| Q1 2023 | +4.7% | +6.7% | -1.0% | |
| Q4 2022 | -4.3% | -5.0% | -2.2% | |
| Q3 2022 | +1.5% | +0.1% | -1.4% | |
| Q2 2022 | -1.7% | -3.6% | -1.1% | |
| Q1 2022 | +6.6% | +0.7% | +7.1% | |
| Q4 2021 | +9.1% | +10.2% | +13.0% | |
| Q3 2021 | -0.8% | -0.6% | -7.7% | |
| Q2 2021 | -7.9% | -8.1% | -13.2% | |
| Q1 2021 | -0.3% | +0.4% | -2.5% | |
| Q4 2020 | +2.1% | +0.4% | +5.9% | |
| Q3 2020 | +10.6% | +5.9% | -1.2% | |
| Q2 2020 | +4.2% | +7.3% | +5.6% | |
| Q1 2020 | +5.2% | +4.1% | +13.2% | |
| Q4 2019 | +4.8% | +3.0% | +7.1% | |
| Q3 2019 | +6.9% | +7.7% | +18.1% | |
| Q2 2019 | +4.8% | +0.8% | -0.5% | |
| Q1 2019 | -3.1% | -2.3% | -4.1% | |
| Q4 2018 | +0.2% | -3.2% | -11.6% | |
| Q3 2018 | +2.3% | +1.8% | -7.8% | |
| Q2 2018 | +2.4% | +2.8% | +6.1% | |
| Q1 2018 | -2.9% | -3.9% | -1.9% | |
| Q4 2017 | -2.5% | -0.8% | +1.3% | |
| Q3 2017 | -3.5% | -6.0% | +0.1% | |
| Q2 2017 | +7.8% | +8.2% | +12.1% | |
| Q1 2017 | +2.0% | +3.9% | +8.4% | |
| Q4 2016 | +6.0% | +5.9% | +11.6% | |
| Q3 2016 | +5.8% | +12.5% | +29.2% | |
| Q2 2016 | +2.5% | +4.8% | +4.6% | |
| Q1 2016 | -1.6% | — | — | |
| Q4 2015 | -0.9% | — | — | |
| Q3 2015 | -0.8% | — | — | |
| Q2 2015 | -0.4% | — | — | |
| Q1 2015 | -8.6% | — | — | |
| Q4 2014 | +1.2% | — | — | |
| Q3 2014 | -5.3% | — | — | |
| Q2 2014 | -7.7% | — | — | |
| Q1 2014 | +6.3% | — | — | |
| Q4 2013 | -0.8% | — | — | |
| Q3 2013 | +1.6% | — | — | |
| Q2 2013 | +2.3% | — | — | |
| Q1 2013 | +1.6% | — | — | |
| Q4 2012 | +7.0% | — | — | |
| Q3 2012 | +1.3% | — | — | |
| Q2 2012 | -12.6% | — | — | |
| Q1 2012 | -4.0% | — | — | |
| Q4 2011 | +1.0% | — | — | |
| Q3 2011 | +4.2% | — | — | |
| Q2 2011 | -2.0% | — | — | |
| Q1 2011 | +1.8% | — | — | |
| Q4 2010 | +3.5% | — | — | |
| Q3 2010 | +4.0% | — | — | |
| Q2 2010 | +4.0% | — | — | |
| Q1 2009 | +4.9% | — | — | |
| Q1 2010 | -0.9% | — | — | |
| Q4 2009 | +3.6% | — | — | |
| Q4 2007 | +3.6% | — | — | |
| Q3 2008 | +5.0% | — | — | |
| Q3 2009 | +5.0% | — | — | |
| Q4 2008 | +2.0% | — | — | |
| Q2 2009 | +2.0% | — | — | |
| Q2 2008 | +2.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro